TrialFrontiers in immunology2022

Early calcineurin-inhibitor to belatacept conversion in steroid-free kidney transplant recipients.

Ibrahim Tawhari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.